OUR SOLUTIONS
CellTherX™ future graft portfolio will consist of microsurfaced human acellular dermal matrix (ADM) grafts produced under the trade name DermaXpress™. These grafts are intended to serve as wound coverings that act as scaffolds to support rapid incorporation, integration and wound closure. DermaXpress™ will be available in multiple sizes and in solid and meshed configurations.
More Information Coming Soon!!!
Figure 1: (A-B) top and side views of DermaXpress™ depicting channels that extend into a portion of the thickness of the graft and (C) top view of DermaXpress™ with the pattern of partial thickness cuts clearly visible as the graft is manually stretched between fingers.
Figure 2: (A) DermaXpress™ after meshing cuts prior to expansion; (B) meshed DermaXpress™ after elongation; and (C) close-up view of meshed DermaXpress™ with the pattern of partial-thickness cuts prominently visible on the surface of intact regions of the graft.
Figure 3: Histology image of a cross-section of a DermaXpress™ graft after H&E staining demonstrating a plurality of partial-thickness cuts on the top surface. Cut depth is approximately 30-50% of the total thickness of the graft.